Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

57

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Immunotherapy for glioblastoma and its microenvironment

Related Posts

Host-pathogen interactions in the Plasmodium-infected mouse liver at spatial and single-cell resolution

Host-pathogen interactions in the Plasmodium-infected m...

44

Spatial biology – unravelling complexity within the glioblastoma microenvironment

Spatial biology – unravelling complexity within the gli...

69

Microbial metabolites tune amygdala neuronal hyperexcitability and anxiety-linked behaviors

Microbial metabolites tune amygdala neuronal hyperexcit...

60